Publication

Article

BioPharm International

BioPharm International-06-02-2003
Volume2003 Supplement
Issue 1

Part 5: Disinfection

Author(s):

Gail Sofer

by Gail Sofer, BioReliance

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue
Part 1: Skin, Bone, and Cells
BioPharm International's Virus Inactivation Series: A Preface
Part 4: Culture Media, Biotechnology Products, and Vaccines
Inactivation of Viruses: An Introduction to the Series
Part 3b: Plasma and Plasma Products (Treatments Other than Heat or Solvent/Detergent)
Part 6: Inactivation Methods Grouped by Virus

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Related Content
Site Logo
September 13th 2025

Industrialize Autologous Therapies

Catalent
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
September 13th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
Digital information travels through fiber optic cables through the network and data servers behind glass panels in the server room of the data center. High speed digital lines 3d illustration | Image Credit: © flashmovie - © flashmovie - stock.adobe.com
September 13th 2025

PDA 2025: How Automation Assures Product Quality for Next-Gen Biopharma

Feliza Mirasol
Mastering Antibody-Drug Conjugates
September 13th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
Brain cancer poster | Image Credit: © pikovit - stock.adobe.com
September 13th 2025

FDA, Telix Agree on NDA Resubmission Pathway for Glioma Imaging Agent

Patrick Lavery
Binary code and lock shape on pixellated screen | Image Credit: © JohanSwanepoel - © JohanSwanepoel - stock.adobe.com
September 13th 2025

PDA 2025: Data Governance and AI's Impact on Drug Manufacturing

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.